Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07751549Completed
Randomised, single-blind trial of metformin 1% gel in acanthosis nigricans (3 arms), sponsored by Tanta University. Primary endpoint: Acanthosis Nigricans Area and Severity Index at 3 months. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07751549.